Pharmacokinetics of Insulin Aspart in Pregnant Women With Type 1 Diabetes: Every Day Is Different

被引：31
|
作者：
Goudie, Robert J. B. [1 ]
Lunn, David [1 ]
Hovorka, Roman [2 ,3 ,4 ]
Murphy, Helen R. [3 ,4 ]
机构：
[1] MRC Biostat Unit, Inst Publ Hlth, Cambridge, England
[2] Univ Cambridge, Dept Paediat, Cambridge, England
[3] Univ Cambridge Wellcome Trust MRC Inst Metab Sci, Level Metab Res Labs 4, Cambridge, England
[4] NIHR Cambridge Biomed Res Ctr, Cambridge, England
来源：
DIABETES CARE | 2014年 / 37卷 / 06期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
D O I：
10.2337/dc13-2535
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E121 / E122
页数：2
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF INSULIN ASPART IN PREGNANT WOMEN WITH TYPE 1 DIABETES: EVERY DAY IS DIFFERENT
    Murphy, H. R.
    Goudie, R. J. B.
    Lunn, D.
    Hovorka, R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A91 - A91
  • [2] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    D. R. McCance
    P. Damm
    E. R. Mathiesen
    M. Hod
    R. Kaaja
    F. Dunne
    L. E. Jensen
    H. Mersebach
    [J]. Diabetologia, 2008, 51 : 2141 - 2143
  • [3] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    McCance, D. R.
    Damm, P.
    Mathiesen, E. R.
    Hod, M.
    Kaaja, R.
    Dunne, F.
    Jensen, L. E.
    Mersebach, H.
    [J]. DIABETOLOGIA, 2008, 51 (11) : 2141 - 2143
  • [4] Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
    Lloyd, A.
    Townsend, C.
    Munro, V.
    Twena, N.
    Nielsen, S.
    Holman, A.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 599 - 605
  • [5] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    [J]. DIABETES, 2003, 52 : A567 - A567
  • [6] Copenfast trial: foetal growth and glycaemic control in pregnant women with type 1 or type 2 diabetes randomised to faster-acting insulin aspart or insulin aspart
    Norgaard, S.
    Soholm, J.
    Mathiesen, E.
    Norgaard, K.
    Clausen, T.
    Holmager, P.
    Do, N.
    Damm, P.
    Ringholm, L.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S122 - S122
  • [7] Renal impairment does not affect insulin aspart pharmacokinetics in type 1 diabetes
    Lyness, W
    Tyler, JF
    Lawrence, A
    [J]. DIABETES, 2001, 50 : A441 - A442
  • [8] A comparison of pharmocodynamics and pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 & Pure Insulin Aspart in type 1 diabetes
    Thorisdottir, Rannveig L.
    Parkner, Tina
    Chen, Jian-Wen
    Ejskjaer, Niels
    Christiansen, Jens S.
    [J]. DIABETES, 2007, 56 : A555 - A555
  • [9] Costs and neonatal outcomes after insulin aspart compared with human insulin in pregnant women with type I diabetes
    Lioxd, A. C.
    Twena, N.
    Townsend, C.
    Holman, A. J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A262 - A262
  • [10] Age-dependent pharmacokinetics of human insulin and insulin aspart in young patients with type 1 diabetes?
    Olsen, B
    Mortensen, H
    Lindholm, A
    Hylleberg, B
    [J]. DIABETOLOGIA, 1999, 42 : A236 - A236
12345